Skip to content

The Influences of Malnutrition and Inflammation Complex Syndrome in Hemodialysis Patients

The Influences of Malnutrition and Inflammation Complex Syndrome in Hemodialysis Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00190125
Enrollment
300
Registered
2005-09-19
Start date
Unknown
Completion date
2007-08-31
Last updated
2009-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Accident, Hemodialysis, Inflammation, Malnutrition, Myocardial Ischemia

Keywords

Hemodialysis, Malnutrition, Inflammation

Brief summary

The purpose of this study is to explore the severity of malnutrition and inflammation in Taiwanese hemodialysis patients.

Detailed description

Cardiovascular disease is the major of cause of mortality of hemodialysis patients. In addition to diabetes and hypertension, malnutrition and chronic inflammation are well-known to be major risk factors of cardiovascular diseases in normal population. For detecting the malnutrition and chronic inflammation and understanding the exact influences to hemodialysis patients, we conduct this study. We will collect the biochemical parameters, inflammatory markers, lipid parameters, hematologic parameters, and genomic DNA of patients. Then we will prospectively record the hospitalization, cardiovascular events, complications of arteriovenous fistula/graft, and mortality. According to the above results, we try to explore the exact role of malnutrition and inflammation in hemodialysis patients.

Interventions

None listed

Sponsors

National Taiwan University
CollaboratorOTHER
Far Eastern Memorial Hospital
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who have received hemodialysis therapy for more than three months

Exclusion criteria

* Having active infection diseases now * Patients who have a malignancy * Had cardiovascular events in recent three months

Countries

Taiwan

Contacts

Primary ContactYu-Sen Peng, M.D.
taan70@yahoo.com.tw886-2-89667000
Backup ContactChih-Kang Chiang, M.D.
ckchiang@mail.femh.org.tw886-2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026